5R01DC016291-05 |
2021 |
$650149 |
Establishing Evidence-based Treatment for Speech and Language in Primary Progressive Aphasia |
5R01DC016291-04 |
2020 |
$650149 |
Establishing Evidence-based Treatment for Speech and Language in Primary Progressive Aphasia |
5R01DC016291-03 |
2019 |
$650149 |
Establishing Evidence-based Treatment for Speech and Language in Primary Progressive Aphasia |
5R01DC016291-02 |
2018 |
$650149 |
Establishing Evidence-based Treatment for Speech and Language in Primary Progressive Aphasia |
1R01DC016291-01 |
2017 |
$673181 |
Establishing Evidence-based Treatment for Speech and Language in Primary Progressive Aphasia |